Anna Mowry
Chief Financial Officer
Replay available
Nautilus Biotechnology, Inc. (NASDAQ: NAUT) Q2 2025 earnings conference call, held 2025-07-31. Replay captured from the company's public earnings webcast.

Chief Financial Officer
Investor Relations
Analyst, TD Cowen
Analyst, Guggenheim
Co-founder and Chief Scientist
Co-founder and Chief Executive Officer
Watch the replay and follow the connected company analysis, news, and investor updates for Nautilus Biotechnology, Inc..
WEBVTT 00:00:00.000 -- 00:00:03.260 Good day, ladies and gentlemen, and thank you for standing by. 00:00:03.260 -- 00:00:09.180 Welcome to the Nautilus Biotechnology Second Quarter 2025 earnings conference call. 00:00:09.180 -- 00:00:12.320 At this time, all participants are on the listen-only mode. 00:00:12.320 -- 00:00:15.860 After the speaker's presentation, there will be a question and answer session. 00:00:15.860 -- 00:00:21.420 To ask a question during that time, you need to press star 1-1 on your telephone keypad. 00:00:21.420 -- 00:00:24.480 At this time, I would like to turn the conference over to Ms. 00:00:24.480 -- 00:00:29.580 Jean-Yong Yi, Investor Relations. Ma'am, please begin. 00:00:29.580 -- 00:00:34.880 Earlier today, Nautilus released financial results for the quarter ended June 30, 00:00:34.880 -- 00:00:36.400 2025. 00:00:36.400 -- 00:00:40.660 If you haven't received this news release or if you'd like to be added to the company's 00:00:40.660 -- 00:00:46.480 distribution list, please send an email to investorrelations at nautilus.bio. 00:00:46.960 -- 00:00:52.000 Joining me today from Nautilus are Sujal Patel, co-founder and CEO, 00:00:52.000 -- 00:00:57.000 Grog Malik, co-founder and chief scientist, and Anna Mowry, 00:00:57.000 -- 00:00:59.440 chief financial officer. 00:00:59.440 -- 00:01:03.620 Before we begin, I'd like to remind you that management will make statements during this 00:01:03.620 -- 00:01:08.500 call that are forward-looking within the meaning of the federal security laws. 00:01:08.500 -- 00:01:13.560 These statements involve material risks and uncertainties that could cause actual results 00:01:13.560 -- 00:01:17.900 or events to materially differ from those anticipated. 00:01:18.100 -- 00:01:21.980 Additional information rega...